The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as the agency’s Oncologic Drugs Advisory ...

The S&P 500 closed at a new record high on Thursday, buoyed by stronger-than-expected retail sales and continued positive momentum in corporate earnings. At the close of trading ,4:00 p.m. ET , the ...